Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
anti cd47 antibody clinical trial | 0.06 | 0.2 | 471 | 26 |
anti cd47 antibody drug | 1.51 | 0.9 | 3196 | 96 |
anti mouse cd47 antibody | 1.21 | 0.5 | 2877 | 56 |
anti-cd47 antibody | 0.11 | 0.9 | 8146 | 25 |
anti cd40 antibody clinical trial | 1.51 | 0.2 | 8683 | 38 |
anti cd47 antibody magrolimab | 1.91 | 0.3 | 4555 | 45 |
anti-cd47 fda approved | 1.43 | 0.1 | 7311 | 36 |
cd24 antibody clinical trial | 1.74 | 0.5 | 3583 | 52 |
anti-cd47 | 0.41 | 0.9 | 3904 | 58 |
targeting cd47 for cancer immunotherapy | 0.54 | 0.6 | 4046 | 40 |
anti-mouse cd47 | 0.73 | 0.7 | 5607 | 34 |
anti cd14 clinical trial | 1.53 | 0.1 | 6164 | 22 |
human cd25 antibody clinical trials | 0.05 | 0.3 | 8006 | 83 |
anti-cd47 mab | 0.46 | 0.7 | 3146 | 25 |
anti-cd248 antibody clinical trials | 1.57 | 1 | 6736 | 23 |
role of cd47 in hematological malignancies | 1.59 | 0.6 | 9216 | 26 |
anti-cd48 phase i trial | 0.46 | 0.7 | 3236 | 63 |
cd20 cd19 cd47 autoimmune lupus | 1.99 | 0.3 | 8045 | 5 |
cd47 red blood cell | 1.45 | 1 | 3653 | 89 |
cd47/cd20 | 1.65 | 0.5 | 5978 | 51 |
leukocyte surface antigen cd47 | 1.67 | 0.4 | 1638 | 82 |
cd20/cd47 | 1.79 | 0.8 | 662 | 43 |